Otsuka Pharmaceutical Development & Commercialization Inc. announced on Wednesday its CEO and president will retire.
William H. Carson, the Princeton-based health care company said, will transition from his role at the helm to chairman of the board of directors.
“Bill is a beloved leader at Otsuka and has been a driving catalyst behind the company’s rapid growth in the years following Otsuka’s establishment of a development organization in the U.S. more than 30 years ago,” Kabir Nath, CEO and president, Otsuka North America pharmaceutical business, said. “Bill has advanced the treatment of mental health for millions of people worldwide. As chairman of the OPDC board of directors, Bill will continue to contribute his unparalleled knowledge and provide strategic guidance to the company.”
Carson joined Otsuka in 2002 as a board-certified psychiatrist. During his tenure, he successfully led the organization through a series of changes, including clinical development, safety, regulatory affairs, data protection and more.
“I am eternally grateful to Otsuka for the opportunity to spend a significant portion of my career helping people living with mental illness,” Carson said. “Along the way, I have had the good fortune of working with so many dedicated, talented professionals who shared the same vision and ideals to help make a difference. I am truly excited about the next phase of my career, which will allow me to continue working with Otsuka and pursue other professional interests.”
